nodes	percent_of_prediction	percent_of_DWPC	metapath
Sulfamethoxazole—CYP2C8—Paclitaxel—ovarian cancer	0.0626	0.249	CbGbCtD
Sulfamethoxazole—CYP3A4—Topotecan—ovarian cancer	0.0513	0.204	CbGbCtD
Sulfamethoxazole—CYP2C9—Paclitaxel—ovarian cancer	0.0437	0.174	CbGbCtD
Sulfamethoxazole—CYP3A4—Vinorelbine—ovarian cancer	0.0362	0.144	CbGbCtD
Sulfamethoxazole—CYP3A4—Paclitaxel—ovarian cancer	0.0254	0.101	CbGbCtD
Sulfamethoxazole—NAT1—myometrium—ovarian cancer	0.0205	0.119	CbGeAlD
Sulfamethoxazole—CYP3A4—Docetaxel—ovarian cancer	0.0184	0.0731	CbGbCtD
Sulfamethoxazole—NAT1—uterine cervix—ovarian cancer	0.016	0.0927	CbGeAlD
Sulfamethoxazole—NAT1—decidua—ovarian cancer	0.0152	0.0884	CbGeAlD
Sulfamethoxazole—NAT1—endometrium—ovarian cancer	0.0144	0.0839	CbGeAlD
Sulfamethoxazole—CYP3A4—Doxorubicin—ovarian cancer	0.0137	0.0545	CbGbCtD
Sulfamethoxazole—NAT1—female reproductive system—ovarian cancer	0.012	0.0695	CbGeAlD
Sulfamethoxazole—NAT1—bone marrow—ovarian cancer	0.0113	0.0656	CbGeAlD
Sulfamethoxazole—NAT1—female gonad—ovarian cancer	0.0109	0.0632	CbGeAlD
Sulfamethoxazole—NAT1—vagina—ovarian cancer	0.0108	0.0628	CbGeAlD
Sulfamethoxazole—PTGS1—oviduct—ovarian cancer	0.01	0.0581	CbGeAlD
Sulfamethoxazole—NAT1—testis—ovarian cancer	0.00965	0.0561	CbGeAlD
Sulfamethoxazole—NAT1—lymph node—ovarian cancer	0.007	0.0406	CbGeAlD
Sulfamethoxazole—CYP2C8—endometrium—ovarian cancer	0.00278	0.0161	CbGeAlD
Sulfamethoxazole—ALB—testis—ovarian cancer	0.00264	0.0154	CbGeAlD
Sulfamethoxazole—PTGS1—epithelium—ovarian cancer	0.00251	0.0146	CbGeAlD
Sulfamethoxazole—PTGS1—uterine cervix—ovarian cancer	0.00249	0.0145	CbGeAlD
Sulfamethoxazole—CYP2C8—female reproductive system—ovarian cancer	0.0023	0.0134	CbGeAlD
Sulfamethoxazole—PTGS1—endometrium—ovarian cancer	0.00225	0.0131	CbGeAlD
Sulfamethoxazole—CYP2C8—vagina—ovarian cancer	0.00208	0.0121	CbGeAlD
Sulfamethoxazole—PTGS1—uterus—ovarian cancer	0.00208	0.0121	CbGeAlD
Sulfamethoxazole—CYP2C9—female reproductive system—ovarian cancer	0.00204	0.0119	CbGeAlD
Sulfamethoxazole—ALB—lymph node—ovarian cancer	0.00192	0.0111	CbGeAlD
Sulfamethoxazole—PTGS1—female reproductive system—ovarian cancer	0.00187	0.0108	CbGeAlD
Sulfamethoxazole—CYP2C8—testis—ovarian cancer	0.00186	0.0108	CbGeAlD
Sulfamethoxazole—PTGS1—female gonad—ovarian cancer	0.0017	0.00987	CbGeAlD
Sulfamethoxazole—PTGS1—vagina—ovarian cancer	0.00169	0.00981	CbGeAlD
Sulfamethoxazole—CYP3A4—female reproductive system—ovarian cancer	0.00156	0.00906	CbGeAlD
Sulfamethoxazole—PTGS1—testis—ovarian cancer	0.00151	0.00875	CbGeAlD
Sulfamethoxazole—PTGS1—lymph node—ovarian cancer	0.00109	0.00634	CbGeAlD
Sulfamethoxazole—Vomiting—Chlorambucil—ovarian cancer	0.000868	0.00157	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Docetaxel—ovarian cancer	0.000867	0.00157	CcSEcCtD
Sulfamethoxazole—Mental disorder—Paclitaxel—ovarian cancer	0.000862	0.00156	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Epirubicin—ovarian cancer	0.000862	0.00156	CcSEcCtD
Sulfamethoxazole—Pruritus—Topotecan—ovarian cancer	0.000859	0.00155	CcSEcCtD
Sulfamethoxazole—Photosensitivity—Doxorubicin—ovarian cancer	0.000857	0.00155	CcSEcCtD
Sulfamethoxazole—Malnutrition—Paclitaxel—ovarian cancer	0.000856	0.00155	CcSEcCtD
Sulfamethoxazole—Renal impairment—Epirubicin—ovarian cancer	0.000854	0.00154	CcSEcCtD
Sulfamethoxazole—Asthenia—Melphalan—ovarian cancer	0.000853	0.00154	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Vinorelbine—ovarian cancer	0.00085	0.00154	CcSEcCtD
Sulfamethoxazole—Purpura—Epirubicin—ovarian cancer	0.000844	0.00152	CcSEcCtD
Sulfamethoxazole—Pruritus—Melphalan—ovarian cancer	0.000842	0.00152	CcSEcCtD
Sulfamethoxazole—Vascular purpura—Doxorubicin—ovarian cancer	0.000841	0.00152	CcSEcCtD
Sulfamethoxazole—Tension—Paclitaxel—ovarian cancer	0.00084	0.00152	CcSEcCtD
Sulfamethoxazole—Hepatitis—Docetaxel—ovarian cancer	0.000834	0.00151	CcSEcCtD
Sulfamethoxazole—Hypoglycaemia—Epirubicin—ovarian cancer	0.000833	0.00151	CcSEcCtD
Sulfamethoxazole—Nervousness—Paclitaxel—ovarian cancer	0.000832	0.0015	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Topotecan—ovarian cancer	0.000831	0.0015	CcSEcCtD
Sulfamethoxazole—Urticaria—Vinorelbine—ovarian cancer	0.000826	0.00149	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Docetaxel—ovarian cancer	0.000824	0.00149	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Vinorelbine—ovarian cancer	0.000821	0.00148	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Vinorelbine—ovarian cancer	0.000821	0.00148	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Docetaxel—ovarian cancer	0.000819	0.00148	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Docetaxel—ovarian cancer	0.000817	0.00148	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Epirubicin—ovarian cancer	0.000816	0.00148	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Melphalan—ovarian cancer	0.000814	0.00147	CcSEcCtD
Sulfamethoxazole—Nausea—Chlorambucil—ovarian cancer	0.000811	0.00146	CcSEcCtD
Sulfamethoxazole—Dizziness—Topotecan—ovarian cancer	0.000803	0.00145	CcSEcCtD
Sulfamethoxazole—Dermatitis exfoliative—Doxorubicin—ovarian cancer	0.000797	0.00144	CcSEcCtD
Sulfamethoxazole—Renal impairment—Doxorubicin—ovarian cancer	0.00079	0.00143	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Docetaxel—ovarian cancer	0.000788	0.00142	CcSEcCtD
Sulfamethoxazole—Angioedema—Paclitaxel—ovarian cancer	0.000783	0.00141	CcSEcCtD
Sulfamethoxazole—Purpura—Doxorubicin—ovarian cancer	0.000781	0.00141	CcSEcCtD
Sulfamethoxazole—Eye disorder—Docetaxel—ovarian cancer	0.000779	0.00141	CcSEcCtD
Sulfamethoxazole—Vomiting—Topotecan—ovarian cancer	0.000772	0.0014	CcSEcCtD
Sulfamethoxazole—Hypoglycaemia—Doxorubicin—ovarian cancer	0.000771	0.00139	CcSEcCtD
Sulfamethoxazole—Vertigo—Paclitaxel—ovarian cancer	0.000769	0.00139	CcSEcCtD
Sulfamethoxazole—Leukopenia—Paclitaxel—ovarian cancer	0.000767	0.00139	CcSEcCtD
Sulfamethoxazole—Rash—Topotecan—ovarian cancer	0.000766	0.00138	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Vinorelbine—ovarian cancer	0.000766	0.00138	CcSEcCtD
Sulfamethoxazole—Dermatitis—Topotecan—ovarian cancer	0.000765	0.00138	CcSEcCtD
Sulfamethoxazole—Ataxia—Epirubicin—ovarian cancer	0.000765	0.00138	CcSEcCtD
Sulfamethoxazole—Headache—Topotecan—ovarian cancer	0.000761	0.00138	CcSEcCtD
Sulfamethoxazole—Vomiting—Melphalan—ovarian cancer	0.000756	0.00137	CcSEcCtD
Sulfamethoxazole—Hyponatraemia—Doxorubicin—ovarian cancer	0.000755	0.00137	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Docetaxel—ovarian cancer	0.000753	0.00136	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Docetaxel—ovarian cancer	0.000752	0.00136	CcSEcCtD
Sulfamethoxazole—Rash—Melphalan—ovarian cancer	0.00075	0.00136	CcSEcCtD
Sulfamethoxazole—Dermatitis—Melphalan—ovarian cancer	0.000749	0.00135	CcSEcCtD
Sulfamethoxazole—Chills—Docetaxel—ovarian cancer	0.000748	0.00135	CcSEcCtD
Sulfamethoxazole—Cough—Paclitaxel—ovarian cancer	0.000747	0.00135	CcSEcCtD
Sulfamethoxazole—Asthenia—Vinorelbine—ovarian cancer	0.000746	0.00135	CcSEcCtD
Sulfamethoxazole—Convulsion—Paclitaxel—ovarian cancer	0.000742	0.00134	CcSEcCtD
Sulfamethoxazole—Pruritus—Vinorelbine—ovarian cancer	0.000735	0.00133	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Epirubicin—ovarian cancer	0.000732	0.00132	CcSEcCtD
Sulfamethoxazole—Mental disorder—Docetaxel—ovarian cancer	0.000731	0.00132	CcSEcCtD
Sulfamethoxazole—Myalgia—Paclitaxel—ovarian cancer	0.000729	0.00132	CcSEcCtD
Sulfamethoxazole—Arthralgia—Paclitaxel—ovarian cancer	0.000729	0.00132	CcSEcCtD
Sulfamethoxazole—Malnutrition—Docetaxel—ovarian cancer	0.000726	0.00131	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—ovarian cancer	0.000724	0.00131	CcSEcCtD
Sulfamethoxazole—Nausea—Topotecan—ovarian cancer	0.000722	0.0013	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Vinorelbine—ovarian cancer	0.000711	0.00129	CcSEcCtD
Sulfamethoxazole—Ataxia—Doxorubicin—ovarian cancer	0.000707	0.00128	CcSEcCtD
Sulfamethoxazole—Nausea—Melphalan—ovarian cancer	0.000707	0.00128	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Paclitaxel—ovarian cancer	0.000699	0.00126	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Epirubicin—ovarian cancer	0.000696	0.00126	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Epirubicin—ovarian cancer	0.000689	0.00125	CcSEcCtD
Sulfamethoxazole—Dizziness—Vinorelbine—ovarian cancer	0.000687	0.00124	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Paclitaxel—ovarian cancer	0.000685	0.00124	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Paclitaxel—ovarian cancer	0.000684	0.00124	CcSEcCtD
Sulfamethoxazole—Skin disorder—Paclitaxel—ovarian cancer	0.000679	0.00123	CcSEcCtD
Sulfamethoxazole—Toxic epidermal necrolysis—Doxorubicin—ovarian cancer	0.000677	0.00122	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Epirubicin—ovarian cancer	0.000667	0.00121	CcSEcCtD
Sulfamethoxazole—Anorexia—Paclitaxel—ovarian cancer	0.000666	0.0012	CcSEcCtD
Sulfamethoxazole—Vomiting—Vinorelbine—ovarian cancer	0.000661	0.00119	CcSEcCtD
Sulfamethoxazole—Neutropenia—Epirubicin—ovarian cancer	0.000657	0.00119	CcSEcCtD
Sulfamethoxazole—Rash—Vinorelbine—ovarian cancer	0.000655	0.00118	CcSEcCtD
Sulfamethoxazole—Dermatitis—Vinorelbine—ovarian cancer	0.000655	0.00118	CcSEcCtD
Sulfamethoxazole—Headache—Vinorelbine—ovarian cancer	0.000651	0.00118	CcSEcCtD
Sulfamethoxazole—Leukopenia—Docetaxel—ovarian cancer	0.00065	0.00117	CcSEcCtD
Sulfamethoxazole—Eosinophilia—Doxorubicin—ovarian cancer	0.000644	0.00116	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Epirubicin—ovarian cancer	0.000641	0.00116	CcSEcCtD
Sulfamethoxazole—Pancreatitis—Doxorubicin—ovarian cancer	0.000637	0.00115	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Paclitaxel—ovarian cancer	0.000637	0.00115	CcSEcCtD
Sulfamethoxazole—Cough—Docetaxel—ovarian cancer	0.000633	0.00114	CcSEcCtD
Sulfamethoxazole—Insomnia—Paclitaxel—ovarian cancer	0.000632	0.00114	CcSEcCtD
Sulfamethoxazole—Pneumonia—Epirubicin—ovarian cancer	0.00063	0.00114	CcSEcCtD
Sulfamethoxazole—Convulsion—Docetaxel—ovarian cancer	0.000629	0.00114	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Epirubicin—ovarian cancer	0.000627	0.00113	CcSEcCtD
Sulfamethoxazole—Infestation—Epirubicin—ovarian cancer	0.000627	0.00113	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Paclitaxel—ovarian cancer	0.000623	0.00113	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Epirubicin—ovarian cancer	0.000621	0.00112	CcSEcCtD
Sulfamethoxazole—Myalgia—Docetaxel—ovarian cancer	0.000618	0.00112	CcSEcCtD
Sulfamethoxazole—Arthralgia—Docetaxel—ovarian cancer	0.000618	0.00112	CcSEcCtD
Sulfamethoxazole—Pancytopenia—Doxorubicin—ovarian cancer	0.000617	0.00112	CcSEcCtD
Sulfamethoxazole—Nausea—Vinorelbine—ovarian cancer	0.000617	0.00112	CcSEcCtD
Sulfamethoxazole—Renal failure—Epirubicin—ovarian cancer	0.000616	0.00111	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Paclitaxel—ovarian cancer	0.000615	0.00111	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Epirubicin—ovarian cancer	0.000614	0.00111	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—ovarian cancer	0.000614	0.00111	CcSEcCtD
Sulfamethoxazole—Stomatitis—Epirubicin—ovarian cancer	0.000611	0.0011	CcSEcCtD
Sulfamethoxazole—Neutropenia—Doxorubicin—ovarian cancer	0.000608	0.0011	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Paclitaxel—ovarian cancer	0.000608	0.0011	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Paclitaxel—ovarian cancer	0.000603	0.00109	CcSEcCtD
Sulfamethoxazole—Fatigue—Paclitaxel—ovarian cancer	0.000603	0.00109	CcSEcCtD
Sulfamethoxazole—Photosensitivity reaction—Doxorubicin—ovarian cancer	0.000593	0.00107	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Epirubicin—ovarian cancer	0.000593	0.00107	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Docetaxel—ovarian cancer	0.000592	0.00107	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Epirubicin—ovarian cancer	0.000585	0.00106	CcSEcCtD
Sulfamethoxazole—Pneumonia—Doxorubicin—ovarian cancer	0.000583	0.00105	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Docetaxel—ovarian cancer	0.000581	0.00105	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Docetaxel—ovarian cancer	0.00058	0.00105	CcSEcCtD
Sulfamethoxazole—Infestation—Doxorubicin—ovarian cancer	0.00058	0.00105	CcSEcCtD
Sulfamethoxazole—Infestation NOS—Doxorubicin—ovarian cancer	0.00058	0.00105	CcSEcCtD
Sulfamethoxazole—Skin disorder—Docetaxel—ovarian cancer	0.000575	0.00104	CcSEcCtD
Sulfamethoxazole—Stevens-Johnson syndrome—Doxorubicin—ovarian cancer	0.000575	0.00104	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Paclitaxel—ovarian cancer	0.000572	0.00103	CcSEcCtD
Sulfamethoxazole—Renal failure—Doxorubicin—ovarian cancer	0.00057	0.00103	CcSEcCtD
Sulfamethoxazole—Neuropathy peripheral—Doxorubicin—ovarian cancer	0.000568	0.00103	CcSEcCtD
Sulfamethoxazole—Stomatitis—Doxorubicin—ovarian cancer	0.000565	0.00102	CcSEcCtD
Sulfamethoxazole—Anorexia—Docetaxel—ovarian cancer	0.000565	0.00102	CcSEcCtD
Sulfamethoxazole—Hepatitis—Epirubicin—ovarian cancer	0.000562	0.00102	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Epirubicin—ovarian cancer	0.000555	0.001	CcSEcCtD
Sulfamethoxazole—Urticaria—Paclitaxel—ovarian cancer	0.000555	0.001	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Epirubicin—ovarian cancer	0.000553	0.000999	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Paclitaxel—ovarian cancer	0.000553	0.000999	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Paclitaxel—ovarian cancer	0.000553	0.000999	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Epirubicin—ovarian cancer	0.000551	0.000996	CcSEcCtD
Sulfamethoxazole—Hepatobiliary disease—Doxorubicin—ovarian cancer	0.000548	0.000991	CcSEcCtD
Sulfamethoxazole—Agranulocytosis—Doxorubicin—ovarian cancer	0.000541	0.000978	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Docetaxel—ovarian cancer	0.00054	0.000976	CcSEcCtD
Sulfamethoxazole—Insomnia—Docetaxel—ovarian cancer	0.000536	0.000968	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Epirubicin—ovarian cancer	0.000532	0.000961	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Docetaxel—ovarian cancer	0.000528	0.000955	CcSEcCtD
Sulfamethoxazole—Eye disorder—Epirubicin—ovarian cancer	0.000526	0.00095	CcSEcCtD
Sulfamethoxazole—Tinnitus—Epirubicin—ovarian cancer	0.000524	0.000948	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Docetaxel—ovarian cancer	0.000522	0.000943	CcSEcCtD
Sulfamethoxazole—Hepatitis—Doxorubicin—ovarian cancer	0.00052	0.000941	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Docetaxel—ovarian cancer	0.000515	0.000931	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Paclitaxel—ovarian cancer	0.000515	0.000931	CcSEcCtD
Sulfamethoxazole—Urinary tract disorder—Doxorubicin—ovarian cancer	0.000514	0.000929	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Docetaxel—ovarian cancer	0.000511	0.000924	CcSEcCtD
Sulfamethoxazole—Connective tissue disorder—Doxorubicin—ovarian cancer	0.000511	0.000924	CcSEcCtD
Sulfamethoxazole—Fatigue—Docetaxel—ovarian cancer	0.000511	0.000923	CcSEcCtD
Sulfamethoxazole—Urethral disorder—Doxorubicin—ovarian cancer	0.00051	0.000922	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Epirubicin—ovarian cancer	0.000508	0.000918	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Epirubicin—ovarian cancer	0.000507	0.000916	CcSEcCtD
Sulfamethoxazole—Chills—Epirubicin—ovarian cancer	0.000505	0.000912	CcSEcCtD
Sulfamethoxazole—Asthenia—Paclitaxel—ovarian cancer	0.000501	0.000906	CcSEcCtD
Sulfamethoxazole—Pruritus—Paclitaxel—ovarian cancer	0.000495	0.000894	CcSEcCtD
Sulfamethoxazole—Mental disorder—Epirubicin—ovarian cancer	0.000493	0.000891	CcSEcCtD
Sulfamethoxazole—Erythema multiforme—Doxorubicin—ovarian cancer	0.000492	0.000889	CcSEcCtD
Sulfamethoxazole—Malnutrition—Epirubicin—ovarian cancer	0.00049	0.000885	CcSEcCtD
Sulfamethoxazole—Eye disorder—Doxorubicin—ovarian cancer	0.000486	0.000879	CcSEcCtD
Sulfamethoxazole—Tinnitus—Doxorubicin—ovarian cancer	0.000485	0.000877	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Docetaxel—ovarian cancer	0.000484	0.000876	CcSEcCtD
Sulfamethoxazole—Tension—Epirubicin—ovarian cancer	0.00048	0.000868	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Paclitaxel—ovarian cancer	0.000478	0.000864	CcSEcCtD
Sulfamethoxazole—Nervousness—Epirubicin—ovarian cancer	0.000476	0.000859	CcSEcCtD
Sulfamethoxazole—Immune system disorder—Doxorubicin—ovarian cancer	0.00047	0.00085	CcSEcCtD
Sulfamethoxazole—Mediastinal disorder—Doxorubicin—ovarian cancer	0.000469	0.000848	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Docetaxel—ovarian cancer	0.000468	0.000846	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Docetaxel—ovarian cancer	0.000468	0.000846	CcSEcCtD
Sulfamethoxazole—Chills—Doxorubicin—ovarian cancer	0.000467	0.000844	CcSEcCtD
Sulfamethoxazole—Dizziness—Paclitaxel—ovarian cancer	0.000462	0.000835	CcSEcCtD
Sulfamethoxazole—Mental disorder—Doxorubicin—ovarian cancer	0.000456	0.000824	CcSEcCtD
Sulfamethoxazole—Malnutrition—Doxorubicin—ovarian cancer	0.000453	0.000819	CcSEcCtD
Sulfamethoxazole—Tension—Doxorubicin—ovarian cancer	0.000445	0.000803	CcSEcCtD
Sulfamethoxazole—Vomiting—Paclitaxel—ovarian cancer	0.000444	0.000803	CcSEcCtD
Sulfamethoxazole—Rash—Paclitaxel—ovarian cancer	0.000441	0.000797	CcSEcCtD
Sulfamethoxazole—Dermatitis—Paclitaxel—ovarian cancer	0.00044	0.000796	CcSEcCtD
Sulfamethoxazole—Nervousness—Doxorubicin—ovarian cancer	0.00044	0.000795	CcSEcCtD
Sulfamethoxazole—Vertigo—Epirubicin—ovarian cancer	0.00044	0.000795	CcSEcCtD
Sulfamethoxazole—Leukopenia—Epirubicin—ovarian cancer	0.000438	0.000792	CcSEcCtD
Sulfamethoxazole—Headache—Paclitaxel—ovarian cancer	0.000438	0.000791	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Docetaxel—ovarian cancer	0.000436	0.000789	CcSEcCtD
Sulfamethoxazole—Cough—Epirubicin—ovarian cancer	0.000427	0.000772	CcSEcCtD
Sulfamethoxazole—Asthenia—Docetaxel—ovarian cancer	0.000425	0.000768	CcSEcCtD
Sulfamethoxazole—Convulsion—Epirubicin—ovarian cancer	0.000424	0.000767	CcSEcCtD
Sulfamethoxazole—Pruritus—Docetaxel—ovarian cancer	0.000419	0.000758	CcSEcCtD
Sulfamethoxazole—Myalgia—Epirubicin—ovarian cancer	0.000417	0.000753	CcSEcCtD
Sulfamethoxazole—Arthralgia—Epirubicin—ovarian cancer	0.000417	0.000753	CcSEcCtD
Sulfamethoxazole—Nausea—Paclitaxel—ovarian cancer	0.000415	0.00075	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—ovarian cancer	0.000414	0.000748	CcSEcCtD
Sulfamethoxazole—Vertigo—Doxorubicin—ovarian cancer	0.000407	0.000736	CcSEcCtD
Sulfamethoxazole—Leukopenia—Doxorubicin—ovarian cancer	0.000406	0.000733	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Docetaxel—ovarian cancer	0.000405	0.000733	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Epirubicin—ovarian cancer	0.0004	0.000722	CcSEcCtD
Sulfamethoxazole—Cough—Doxorubicin—ovarian cancer	0.000395	0.000714	CcSEcCtD
Sulfamethoxazole—Convulsion—Doxorubicin—ovarian cancer	0.000393	0.000709	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Epirubicin—ovarian cancer	0.000392	0.000708	CcSEcCtD
Sulfamethoxazole—Dizziness—Docetaxel—ovarian cancer	0.000392	0.000708	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Epirubicin—ovarian cancer	0.000391	0.000707	CcSEcCtD
Sulfamethoxazole—Skin disorder—Epirubicin—ovarian cancer	0.000388	0.000702	CcSEcCtD
Sulfamethoxazole—Myalgia—Doxorubicin—ovarian cancer	0.000386	0.000697	CcSEcCtD
Sulfamethoxazole—Arthralgia—Doxorubicin—ovarian cancer	0.000386	0.000697	CcSEcCtD
Sulfamethoxazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—ovarian cancer	0.000383	0.000692	CcSEcCtD
Sulfamethoxazole—Anorexia—Epirubicin—ovarian cancer	0.000381	0.000688	CcSEcCtD
Sulfamethoxazole—Vomiting—Docetaxel—ovarian cancer	0.000377	0.000681	CcSEcCtD
Sulfamethoxazole—Rash—Docetaxel—ovarian cancer	0.000374	0.000675	CcSEcCtD
Sulfamethoxazole—Dermatitis—Docetaxel—ovarian cancer	0.000373	0.000674	CcSEcCtD
Sulfamethoxazole—Headache—Docetaxel—ovarian cancer	0.000371	0.000671	CcSEcCtD
Sulfamethoxazole—Anaphylactic shock—Doxorubicin—ovarian cancer	0.00037	0.000668	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Epirubicin—ovarian cancer	0.000364	0.000658	CcSEcCtD
Sulfamethoxazole—Nervous system disorder—Doxorubicin—ovarian cancer	0.000363	0.000655	CcSEcCtD
Sulfamethoxazole—Thrombocytopenia—Doxorubicin—ovarian cancer	0.000362	0.000654	CcSEcCtD
Sulfamethoxazole—Insomnia—Epirubicin—ovarian cancer	0.000361	0.000653	CcSEcCtD
Sulfamethoxazole—Skin disorder—Doxorubicin—ovarian cancer	0.000359	0.000649	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Epirubicin—ovarian cancer	0.000356	0.000644	CcSEcCtD
Sulfamethoxazole—Anorexia—Doxorubicin—ovarian cancer	0.000352	0.000637	CcSEcCtD
Sulfamethoxazole—Nausea—Docetaxel—ovarian cancer	0.000352	0.000636	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Epirubicin—ovarian cancer	0.000352	0.000636	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Epirubicin—ovarian cancer	0.000347	0.000628	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Epirubicin—ovarian cancer	0.000345	0.000624	CcSEcCtD
Sulfamethoxazole—Fatigue—Epirubicin—ovarian cancer	0.000345	0.000623	CcSEcCtD
Sulfamethoxazole—Musculoskeletal discomfort—Doxorubicin—ovarian cancer	0.000337	0.000609	CcSEcCtD
Sulfamethoxazole—Insomnia—Doxorubicin—ovarian cancer	0.000334	0.000604	CcSEcCtD
Sulfamethoxazole—Dyspnoea—Doxorubicin—ovarian cancer	0.00033	0.000596	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Epirubicin—ovarian cancer	0.000327	0.000591	CcSEcCtD
Sulfamethoxazole—Dyspepsia—Doxorubicin—ovarian cancer	0.000325	0.000588	CcSEcCtD
Sulfamethoxazole—Decreased appetite—Doxorubicin—ovarian cancer	0.000321	0.000581	CcSEcCtD
Sulfamethoxazole—Gastrointestinal disorder—Doxorubicin—ovarian cancer	0.000319	0.000577	CcSEcCtD
Sulfamethoxazole—Fatigue—Doxorubicin—ovarian cancer	0.000319	0.000576	CcSEcCtD
Sulfamethoxazole—Urticaria—Epirubicin—ovarian cancer	0.000317	0.000574	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Epirubicin—ovarian cancer	0.000316	0.000571	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Epirubicin—ovarian cancer	0.000316	0.000571	CcSEcCtD
Sulfamethoxazole—Gastrointestinal pain—Doxorubicin—ovarian cancer	0.000302	0.000546	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Epirubicin—ovarian cancer	0.000294	0.000532	CcSEcCtD
Sulfamethoxazole—Urticaria—Doxorubicin—ovarian cancer	0.000294	0.000531	CcSEcCtD
Sulfamethoxazole—Abdominal pain—Doxorubicin—ovarian cancer	0.000292	0.000528	CcSEcCtD
Sulfamethoxazole—Body temperature increased—Doxorubicin—ovarian cancer	0.000292	0.000528	CcSEcCtD
Sulfamethoxazole—Asthenia—Epirubicin—ovarian cancer	0.000287	0.000518	CcSEcCtD
Sulfamethoxazole—Pruritus—Epirubicin—ovarian cancer	0.000283	0.000511	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Epirubicin—ovarian cancer	0.000273	0.000494	CcSEcCtD
Sulfamethoxazole—Hypersensitivity—Doxorubicin—ovarian cancer	0.000272	0.000492	CcSEcCtD
Sulfamethoxazole—Asthenia—Doxorubicin—ovarian cancer	0.000265	0.000479	CcSEcCtD
Sulfamethoxazole—Dizziness—Epirubicin—ovarian cancer	0.000264	0.000478	CcSEcCtD
Sulfamethoxazole—Pruritus—Doxorubicin—ovarian cancer	0.000262	0.000473	CcSEcCtD
Sulfamethoxazole—Vomiting—Epirubicin—ovarian cancer	0.000254	0.000459	CcSEcCtD
Sulfamethoxazole—Diarrhoea—Doxorubicin—ovarian cancer	0.000253	0.000457	CcSEcCtD
Sulfamethoxazole—Rash—Epirubicin—ovarian cancer	0.000252	0.000455	CcSEcCtD
Sulfamethoxazole—Dermatitis—Epirubicin—ovarian cancer	0.000252	0.000455	CcSEcCtD
Sulfamethoxazole—Headache—Epirubicin—ovarian cancer	0.00025	0.000452	CcSEcCtD
Sulfamethoxazole—Dizziness—Doxorubicin—ovarian cancer	0.000245	0.000442	CcSEcCtD
Sulfamethoxazole—Nausea—Epirubicin—ovarian cancer	0.000237	0.000429	CcSEcCtD
Sulfamethoxazole—Vomiting—Doxorubicin—ovarian cancer	0.000235	0.000425	CcSEcCtD
Sulfamethoxazole—Rash—Doxorubicin—ovarian cancer	0.000233	0.000421	CcSEcCtD
Sulfamethoxazole—Dermatitis—Doxorubicin—ovarian cancer	0.000233	0.000421	CcSEcCtD
Sulfamethoxazole—Headache—Doxorubicin—ovarian cancer	0.000232	0.000419	CcSEcCtD
Sulfamethoxazole—Nausea—Doxorubicin—ovarian cancer	0.00022	0.000397	CcSEcCtD
Sulfamethoxazole—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—ovarian cancer	9.49e-05	0.00407	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—SOD1—ovarian cancer	9.14e-05	0.00392	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—ovarian cancer	9.04e-05	0.00388	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—SOD1—ovarian cancer	8.71e-05	0.00374	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Biological oxidations—CYP1B1—ovarian cancer	8.66e-05	0.00371	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Tryptophan metabolism—CYP1B1—ovarian cancer	8.62e-05	0.0037	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	8.57e-05	0.00367	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—SOD1—ovarian cancer	8.47e-05	0.00363	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—CAV1—ovarian cancer	8.19e-05	0.00351	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	8.19e-05	0.00351	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—SOD2—ovarian cancer	7.63e-05	0.00327	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PIK3CG—ovarian cancer	7.46e-05	0.0032	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—YAP1—ovarian cancer	7.03e-05	0.00302	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—ovarian cancer	6.97e-05	0.00299	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—ovarian cancer	6.88e-05	0.00295	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	6.68e-05	0.00286	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PIK3CD—ovarian cancer	6.56e-05	0.00281	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—NME2—ovarian cancer	6.48e-05	0.00278	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—FASN—ovarian cancer	5.73e-05	0.00246	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PIK3CB—ovarian cancer	5.72e-05	0.00245	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—ovarian cancer	5.65e-05	0.00242	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—SLC5A5—ovarian cancer	5.64e-05	0.00242	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Biological oxidations—CYP1B1—ovarian cancer	5.59e-05	0.0024	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—SPARC—ovarian cancer	5.58e-05	0.00239	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metapathway biotransformation—CYP1B1—ovarian cancer	5.52e-05	0.00237	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	5.49e-05	0.00236	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—SLC2A1—ovarian cancer	5.44e-05	0.00233	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—RAD51C—ovarian cancer	5.39e-05	0.00231	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—NME2—ovarian cancer	5.28e-05	0.00226	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CYP1B1—ovarian cancer	5.22e-05	0.00224	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IL2—ovarian cancer	5e-05	0.00214	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PTEN—ovarian cancer	4.94e-05	0.00212	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PPP2R1A—ovarian cancer	4.63e-05	0.00199	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Biological oxidations—CYP1B1—ovarian cancer	4.55e-05	0.00195	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metapathway biotransformation—CYP1B1—ovarian cancer	4.49e-05	0.00193	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	4.48e-05	0.00192	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	4.48e-05	0.00192	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—AQP3—ovarian cancer	4.34e-05	0.00186	CbGpPWpGaD
Sulfamethoxazole—ALB—SLC-mediated transmembrane transport—SLC5A5—ovarian cancer	4.31e-05	0.00185	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	4.31e-05	0.00185	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—ABCB1—ovarian cancer	4.3e-05	0.00184	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	4.29e-05	0.00184	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—TYMS—ovarian cancer	4.22e-05	0.00181	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYTB—ovarian cancer	4.17e-05	0.00179	CbGpPWpGaD
Sulfamethoxazole—ALB—SLC-mediated transmembrane transport—SLC2A1—ovarian cancer	4.17e-05	0.00179	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—ATP7B—ovarian cancer	4.16e-05	0.00178	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	4.08e-05	0.00175	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—SOD1—ovarian cancer	4.06e-05	0.00174	CbGpPWpGaD
Sulfamethoxazole—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—ovarian cancer	3.75e-05	0.00161	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	3.65e-05	0.00157	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—BRIP1—ovarian cancer	3.65e-05	0.00156	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PPP1CC—ovarian cancer	3.65e-05	0.00156	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet degranulation—VEGFA—ovarian cancer	3.64e-05	0.00156	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Selenium Micronutrient Network—IL6—ovarian cancer	3.63e-05	0.00156	CbGpPWpGaD
Sulfamethoxazole—ALB—Vitamin B12 Metabolism—IL6—ovarian cancer	3.61e-05	0.00155	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PPP1CC—ovarian cancer	3.51e-05	0.00151	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—PIK3CA—ovarian cancer	3.49e-05	0.00149	CbGpPWpGaD
Sulfamethoxazole—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—ovarian cancer	3.47e-05	0.00149	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—NME2—ovarian cancer	3.41e-05	0.00146	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYTB—ovarian cancer	3.4e-05	0.00146	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—CAV1—ovarian cancer	3.4e-05	0.00146	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—NME2—ovarian cancer	3.39e-05	0.00145	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	3.32e-05	0.00143	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—TUBB3—ovarian cancer	3.29e-05	0.00141	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—TP53—ovarian cancer	3.21e-05	0.00138	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PIK3CG—ovarian cancer	3.1e-05	0.00133	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Biological oxidations—CYP1B1—ovarian cancer	3e-05	0.00129	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PPP1CC—ovarian cancer	2.97e-05	0.00128	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—BRIP1—ovarian cancer	2.97e-05	0.00128	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metapathway biotransformation—CYP1B1—ovarian cancer	2.96e-05	0.00127	CbGpPWpGaD
Sulfamethoxazole—ALB—Folate Metabolism—IL6—ovarian cancer	2.94e-05	0.00126	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.89e-05	0.00124	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SPARC—ovarian cancer	2.88e-05	0.00123	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.88e-05	0.00123	CbGpPWpGaD
Sulfamethoxazole—NAT1—Metabolism—AKT1—ovarian cancer	2.85e-05	0.00122	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—NME2—ovarian cancer	2.78e-05	0.00119	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PIK3CD—ovarian cancer	2.72e-05	0.00117	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PIK3CG—ovarian cancer	2.7e-05	0.00116	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.66e-05	0.00114	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—YAP1—ovarian cancer	2.45e-05	0.00105	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	2.42e-05	0.00104	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PIK3CD—ovarian cancer	2.37e-05	0.00102	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PIK3CB—ovarian cancer	2.37e-05	0.00102	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.36e-05	0.00101	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—YAP1—ovarian cancer	2.35e-05	0.00101	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	2.34e-05	0.00101	CbGpPWpGaD
Sulfamethoxazole—ALB—Selenium Micronutrient Network—IL6—ovarian cancer	2.33e-05	0.001	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYTB—ovarian cancer	2.2e-05	0.000942	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC5A5—ovarian cancer	2.19e-05	0.00094	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYTB—ovarian cancer	2.18e-05	0.000937	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	2.17e-05	0.000929	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.15e-05	0.000921	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	2.14e-05	0.000916	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	2.13e-05	0.000913	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—SLC2A1—ovarian cancer	2.12e-05	0.000908	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—SOD1—ovarian cancer	2.09e-05	0.000897	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PPP2R1A—ovarian cancer	2.08e-05	0.000892	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PIK3CB—ovarian cancer	2.07e-05	0.000888	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PTEN—ovarian cancer	2.05e-05	0.00088	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—YAP1—ovarian cancer	1.99e-05	0.000855	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—FASN—ovarian cancer	1.99e-05	0.000855	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.97e-05	0.000846	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—SLC5A5—ovarian cancer	1.96e-05	0.000841	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPP1CC—ovarian cancer	1.92e-05	0.000824	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—BRIP1—ovarian cancer	1.92e-05	0.000824	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—FASN—ovarian cancer	1.92e-05	0.000823	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPP1CC—ovarian cancer	1.91e-05	0.000819	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—BRIP1—ovarian cancer	1.91e-05	0.000819	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—IL2—ovarian cancer	1.9e-05	0.000815	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—SLC2A1—ovarian cancer	1.89e-05	0.000813	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.86e-05	0.000796	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—NME2—ovarian cancer	1.83e-05	0.000785	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CYP1B1—ovarian cancer	1.82e-05	0.000779	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYTB—ovarian cancer	1.79e-05	0.000767	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1B1—ovarian cancer	1.75e-05	0.00075	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.73e-05	0.000744	CbGpPWpGaD
Sulfamethoxazole—ALB—Transmembrane transport of small molecules—ABCB1—ovarian cancer	1.67e-05	0.000717	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—FASN—ovarian cancer	1.63e-05	0.000697	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—VEGFA—ovarian cancer	1.62e-05	0.000693	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PPP2R1A—ovarian cancer	1.61e-05	0.000691	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.6e-05	0.000687	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—SLC5A5—ovarian cancer	1.6e-05	0.000686	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPP1CC—ovarian cancer	1.56e-05	0.00067	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—BRIP1—ovarian cancer	1.56e-05	0.00067	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—SLC2A1—ovarian cancer	1.54e-05	0.000662	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—CAV1—ovarian cancer	1.53e-05	0.000656	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—MAPK3—ovarian cancer	1.53e-05	0.000655	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	1.51e-05	0.000649	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—ABCB1—ovarian cancer	1.5e-05	0.000641	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CYP1B1—ovarian cancer	1.48e-05	0.000635	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—TYMS—ovarian cancer	1.47e-05	0.00063	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—MAPK1—ovarian cancer	1.45e-05	0.000624	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—PIK3CA—ovarian cancer	1.45e-05	0.000621	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.4e-05	0.0006	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CG—ovarian cancer	1.39e-05	0.000597	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.39e-05	0.000597	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PPP2R1A—ovarian cancer	1.31e-05	0.000563	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	1.31e-05	0.00056	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—YAP1—ovarian cancer	1.29e-05	0.000552	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—YAP1—ovarian cancer	1.28e-05	0.000549	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.27e-05	0.000547	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.27e-05	0.000544	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—PIK3CA—ovarian cancer	1.26e-05	0.000541	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CD—ovarian cancer	1.22e-05	0.000525	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—ABCB1—ovarian cancer	1.22e-05	0.000523	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—TYMS—ovarian cancer	1.2e-05	0.000514	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—CAV1—ovarian cancer	1.18e-05	0.000508	CbGpPWpGaD
Sulfamethoxazole—NAT2—Metabolism—AKT1—ovarian cancer	1.18e-05	0.000507	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYTB—ovarian cancer	1.18e-05	0.000506	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—CAV1—ovarian cancer	1.14e-05	0.000489	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	1.13e-05	0.000485	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.12e-05	0.000481	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	1.11e-05	0.000478	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CG—ovarian cancer	1.08e-05	0.000462	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CB—ovarian cancer	1.07e-05	0.000458	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—FASN—ovarian cancer	1.05e-05	0.00045	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—YAP1—ovarian cancer	1.05e-05	0.00045	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—FASN—ovarian cancer	1.04e-05	0.000448	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—ovarian cancer	1.04e-05	0.000445	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SLC5A5—ovarian cancer	1.03e-05	0.000443	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—BRIP1—ovarian cancer	1.03e-05	0.000442	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPP1CC—ovarian cancer	1.03e-05	0.000442	CbGpPWpGaD
Sulfamethoxazole—ALB—Platelet activation, signaling and aggregation—AKT1—ovarian cancer	1.03e-05	0.000442	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SLC5A5—ovarian cancer	1.03e-05	0.00044	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—SLC2A1—ovarian cancer	9.98e-06	0.000428	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—SLC2A1—ovarian cancer	9.92e-06	0.000425	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—IL2—ovarian cancer	9.8e-06	0.00042	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.77e-06	0.000419	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	9.71e-06	0.000417	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—CAV1—ovarian cancer	9.65e-06	0.000414	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CYP1B1—ovarian cancer	9.56e-06	0.00041	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CYP1B1—ovarian cancer	9.51e-06	0.000408	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CD—ovarian cancer	9.48e-06	0.000407	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	9.22e-06	0.000395	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—ovarian cancer	9.12e-06	0.000391	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CG—ovarian cancer	8.79e-06	0.000377	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—FASN—ovarian cancer	8.55e-06	0.000367	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PPP2R1A—ovarian cancer	8.48e-06	0.000364	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.44e-06	0.000362	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PPP2R1A—ovarian cancer	8.43e-06	0.000362	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC5A5—ovarian cancer	8.41e-06	0.000361	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	8.39e-06	0.00036	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—VEGFA—ovarian cancer	8.33e-06	0.000357	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CB—ovarian cancer	8.26e-06	0.000354	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—NRAS—ovarian cancer	8.22e-06	0.000353	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—SLC2A1—ovarian cancer	8.12e-06	0.000348	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—ovarian cancer	7.95e-06	0.000341	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MAPK3—ovarian cancer	7.88e-06	0.000338	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—ABCB1—ovarian cancer	7.88e-06	0.000338	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—ABCB1—ovarian cancer	7.83e-06	0.000336	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CYP1B1—ovarian cancer	7.78e-06	0.000334	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—TYMS—ovarian cancer	7.73e-06	0.000332	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CD—ovarian cancer	7.73e-06	0.000331	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—TYMS—ovarian cancer	7.69e-06	0.00033	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—MAPK1—ovarian cancer	7.49e-06	0.000321	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PTEN—ovarian cancer	7.14e-06	0.000306	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—KRAS—ovarian cancer	7.08e-06	0.000304	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—YAP1—ovarian cancer	6.91e-06	0.000297	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PPP2R1A—ovarian cancer	6.9e-06	0.000296	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—ovarian cancer	6.87e-06	0.000295	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CB—ovarian cancer	6.73e-06	0.000289	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—PIK3CA—ovarian cancer	6.5e-06	0.000279	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—ABCB1—ovarian cancer	6.41e-06	0.000275	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—TYMS—ovarian cancer	6.3e-06	0.00027	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—TP53—ovarian cancer	6.29e-06	0.00027	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—CAV1—ovarian cancer	6.23e-06	0.000267	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—CAV1—ovarian cancer	6.2e-06	0.000266	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—HRAS—ovarian cancer	6.02e-06	0.000258	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.95e-06	0.000255	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	5.92e-06	0.000254	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PTEN—ovarian cancer	5.82e-06	0.00025	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CG—ovarian cancer	5.68e-06	0.000243	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CG—ovarian cancer	5.64e-06	0.000242	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—FASN—ovarian cancer	5.64e-06	0.000242	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC5A5—ovarian cancer	5.54e-06	0.000238	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—SLC2A1—ovarian cancer	5.35e-06	0.00023	CbGpPWpGaD
Sulfamethoxazole—ALB—Hemostasis—AKT1—ovarian cancer	5.31e-06	0.000228	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CYP1B1—ovarian cancer	5.13e-06	0.00022	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—CAV1—ovarian cancer	5.07e-06	0.000218	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—PIK3CA—ovarian cancer	5.04e-06	0.000216	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CD—ovarian cancer	4.99e-06	0.000214	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CD—ovarian cancer	4.96e-06	0.000213	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—ovarian cancer	4.85e-06	0.000208	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CG—ovarian cancer	4.62e-06	0.000198	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PPP2R1A—ovarian cancer	4.55e-06	0.000195	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CB—ovarian cancer	4.35e-06	0.000187	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CB—ovarian cancer	4.33e-06	0.000186	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—ABCB1—ovarian cancer	4.23e-06	0.000181	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—TYMS—ovarian cancer	4.15e-06	0.000178	CbGpPWpGaD
Sulfamethoxazole—UGT1A9—Metabolism—AKT1—ovarian cancer	4.11e-06	0.000176	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—PIK3CA—ovarian cancer	4.11e-06	0.000176	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CD—ovarian cancer	4.06e-06	0.000174	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PTEN—ovarian cancer	3.76e-06	0.000161	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PTEN—ovarian cancer	3.74e-06	0.00016	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CB—ovarian cancer	3.54e-06	0.000152	CbGpPWpGaD
Sulfamethoxazole—PTGS1—Metabolism—AKT1—ovarian cancer	3.35e-06	0.000144	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—CAV1—ovarian cancer	3.35e-06	0.000143	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PTEN—ovarian cancer	3.06e-06	0.000131	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CG—ovarian cancer	3.05e-06	0.000131	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CD—ovarian cancer	2.68e-06	0.000115	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—PIK3CA—ovarian cancer	2.65e-06	0.000114	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—PIK3CA—ovarian cancer	2.64e-06	0.000113	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CB—ovarian cancer	2.33e-06	0.0001	CbGpPWpGaD
Sulfamethoxazole—CYP2C8—Metabolism—AKT1—ovarian cancer	2.17e-06	9.29e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—PIK3CA—ovarian cancer	2.16e-06	9.26e-05	CbGpPWpGaD
Sulfamethoxazole—ALB—Metabolism—AKT1—ovarian cancer	2.15e-06	9.24e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PTEN—ovarian cancer	2.02e-06	8.65e-05	CbGpPWpGaD
Sulfamethoxazole—CYP2C9—Metabolism—AKT1—ovarian cancer	1.76e-06	7.56e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—PIK3CA—ovarian cancer	1.42e-06	6.1e-05	CbGpPWpGaD
Sulfamethoxazole—CYP3A4—Metabolism—AKT1—ovarian cancer	1.16e-06	4.99e-05	CbGpPWpGaD
